Skip to content

Aldehyde breath test as a disease marker in patients with digestive disease

Aldehyde breath test as a disease marker in patients with esophageal and hypopharyngeal squamous cell carcinoma - Aldehyde breath test as a disease marker in patients with esophageal and hypopharyngeal squamous cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040615
Enrollment
500
Registered
2020-06-01
Start date
2016-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive disease

Interventions

None listed

Sponsors

Kagoshima University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with digestive disorders over the age of 20 Patients examined in a medical checkup over the age of 20

Exclusion criteria

Exclusion criteria: (1) history of surgical resection of any part of the upper gastrointestinal tract, (2) history of alcohol allergy, (3) age below 20 years, (4) current pregnancy.

Design outcomes

Primary

MeasureTime frame
ALDH2 gene polymorphism in digestive diseases

Countries

Japan

Contacts

Public ContactFumisato Sasaki

Digestive and Lifestyle Diseases Department of Human and Environmental Sciences

bungohs@m2.kufm.kagoshima-u.ac.jp099-275-5326

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026